Previous analyses and systematic meta-analyses have shown that higher levels of tumor-infiltrating lymphocytes (TILs), especially CD3 + and CD8 + TILs, are associated with improved survival in HNSCC patients receiving (chemo)radiotherapy [16–23]. Here, CD8A is linked to neoplasm.